Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Afshin Mashadi-Hossein

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Lab on a Chip|March 29, 2008
Experimental and model investigation of the time-dependent 2-dimensional distribution of binding in a herringbone microchannelJennifer O Foley, Afshin Mashadi-Hossein, Elain Fu, et al.
Analytical Chemistry|April 18, 2007
Concentration gradient immunoassay. 2. Computational modeling for analysis and optimizationJennifer O Foley, Kjell E Nelson, Afshin Mashadi-Hossein, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Development of Gene Expression-Based Biomarkers on the nCounter<sup>®</sup> Platform for Immuno-Oncology ApplicationsSarah Warren, Patrick Danaher, Afshin Mashadi-Hossein, et al.
BMC Research Notes|May 12, 2009
Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter Assay SystemVladislav A Malkov, Kyle A Serikawa, Noel Balantac, et al.
Analytica Chimica Acta|February 27, 2008
Demonstration of multi-analyte patterning using piezoelectric inkjet printing of multiple layersMelissa S Hasenbank, Thayne Edwards, Elain Fu, et al.
Frontiers in Immunology|February 15, 2019
CD56<sup>dim</sup> CD16<sup>-</sup> Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-αLazar Vujanovic, Christopher Chuckran, Yan Lin, et al.
Cancer Research|July 29, 2015
Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic CancerTong Li, Yak-Nam Wang, Tatiana D Khokhlova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2019
Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31Saranya Chumsri, Zhuo Li, Daniel J Serie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) TrialsSaranya Chumsri, Daniel J Serie, Zhuo Li, et al.
Journal of the National Cancer Institute|October 30, 2016
Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 TrialEdith A Perez, Karla V Ballman, Afshin Mashadi-Hossein, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Lab on a Chip|March 29, 2008
Experimental and model investigation of the time-dependent 2-dimensional distribution of binding in a herringbone microchannelJennifer O Foley, Afshin Mashadi-Hossein, Elain Fu, et al.
Analytical Chemistry|April 18, 2007
Concentration gradient immunoassay. 2. Computational modeling for analysis and optimizationJennifer O Foley, Kjell E Nelson, Afshin Mashadi-Hossein, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Development of Gene Expression-Based Biomarkers on the nCounter<sup>®</sup> Platform for Immuno-Oncology ApplicationsSarah Warren, Patrick Danaher, Afshin Mashadi-Hossein, et al.
BMC Research Notes|May 12, 2009
Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter Assay SystemVladislav A Malkov, Kyle A Serikawa, Noel Balantac, et al.
Analytica Chimica Acta|February 27, 2008
Demonstration of multi-analyte patterning using piezoelectric inkjet printing of multiple layersMelissa S Hasenbank, Thayne Edwards, Elain Fu, et al.
Frontiers in Immunology|February 15, 2019
CD56<sup>dim</sup> CD16<sup>-</sup> Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-αLazar Vujanovic, Christopher Chuckran, Yan Lin, et al.
Cancer Research|July 29, 2015
Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic CancerTong Li, Yak-Nam Wang, Tatiana D Khokhlova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2019
Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31Saranya Chumsri, Zhuo Li, Daniel J Serie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) TrialsSaranya Chumsri, Daniel J Serie, Zhuo Li, et al.
Journal of the National Cancer Institute|October 30, 2016
Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 TrialEdith A Perez, Karla V Ballman, Afshin Mashadi-Hossein, et al.
Pageof 2